FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/106965 [Registered on: 27/03/2026] Trial Registered Prospectively
Last Modified On: 26/03/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   A study to evaluate the effect of one percent Resveratrol gel and one percent Chitosan gel on bone healing and stability of dental implants 
Scientific Title of Study   Effect of one percent Resveratrol gel and one percent Chitosan gel application on osseointegration and crestal bone changes around dental implants 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aitha Lakshmi Pranathi 
Designation  Post Graduate  
Affiliation  Sibar Institute of Dental Sciences 
Address  Department of Periodontology, Room no-8, Sibar Institute of Dental sciences, Takkellapadu, Guntur

Guntur
ANDHRA PRADESH
522509
India 
Phone  8688228638  
Fax    
Email  pranathiaitha23@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Boyapati Ramanarayana 
Designation  Professor 
Affiliation  Sibar Institute of Dental Sciences 
Address  Department of Periodontology, Room no-8, Sibar Institute of Dental sciences, Takkellapadu, Guntur

Guntur
ANDHRA PRADESH
522509
India 
Phone  9490144365  
Fax    
Email  dr.ramanarayana@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Aitha Lakshmi Pranathi 
Designation  Post Graduate  
Affiliation  Sibar Institute of Dental Sciences 
Address  Department of Periodontology, Room no-8, Sibar Institute of Dental sciences, Takkellapadu, Guntur

Guntur
ANDHRA PRADESH
522509
India 
Phone  8688228638  
Fax    
Email  pranathiaitha23@gmail.com  
 
Source of Monetary or Material Support  
Department of Periodontology, Room no-8, Sibar Institute of Dental sciences, Takkellapadu, Guntur,Andhra Pradesh ,India,Pincode- 522509 
 
Primary Sponsor  
Name  Aitha Lakshmi Pranathi 
Address  Department of Periodontology, Room no-8, Sibar Institute of Dental sciences, Takkellapadu, Guntur, Andhra Pradesh, India, Pincode-522509 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aitha Lakshmi Pranathi  Sibar Institute of Dental Sciences  Department of Periodontology, Room no-8, Sibar Institute of Dental sciences, Takkellapadu, Guntur, Andhra Pradesh, India, Pincode-522509
Guntur
ANDHRA PRADESH 
8688228638

pranathiaitha23@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committe- SIBAR INSTITUTE OF DENTAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: X||New Technology,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Conventional implant placement  Implants will be placed following conventional surgical protocol without the application of any adjunctive gel material. This group will serve as the control for comparison of implant stability (RFA values) and crestal bone level changes (grid IOPA analysis).  
Intervention  One percent chitosan gel   Gel will be applied locally on the implant prior to implant insertion into the osteotomy site immediately to evaluate its effect on osseointegration and crestal bone changes. 
Intervention  One Percent Resveratrol gel   Gel will be applied locally on the implant prior to implant insertion into the osteotomy site immediately to evaluate its effect on osseointegration and crestal bone changes. 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Subjects with partial edentulism indicated for implant-supported tooth replacement.
2.Individuals with an age group of 35-50 years of either gender.
3.Presence of adequate keratinized mucosa (minimum 1 mm) in the edentulous site.
4.Apparently healthy individuals.
5.Individuals with bone density classified as D2 and D3 type of bone.
 
 
ExclusionCriteria 
Details  1.Individuals with parafunctional habits.
2.Any forms of tobacco users.
3.Pregnant and lactating women.
4.Subjects taking any medication which effect healing and bone metabolism.
5.Subjects with a history of immune disease, uncontrolled diabetes, ongoing chemotherapy radiation treatment to head and neck, alcohol or drug abuse, or psychological instability.
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Clinical outcome - Implant stability
Radiological outcome – bone density and bone width, Crestal bone level changes 
Time points(clinical outcome) –Immediate post op ,3 months
Time points(Radiological outcomes)- Immediate post op,
3 months, 6 months 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/05/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Successful dental implantation depends on optimal osseointegration and maintenance of crestal bone levels. Resveratrol (a polyphenolic compound with anti-inflammatory and osteogenic properties) and chitosan (a biocompatible polymer with osteoconductive and antimicrobial effects) may enhance peri-implant healing; however, clinical evidence regarding their local application is limited.

This randomized controlled clinical study will evaluate the effect of one percent resveratrol gel and one percent chitosan gel on osseointegration and crestal bone changes around dental implants. Thirty implants will be allocated into three groups (ten each): Group one (control group), Group two (one percent resveratrol gel), and Group three (one percent chitosan gel).Implant stability (ISQ) will be assessed using Resonance Frequency Analysis (RFA), and crestal bone levels will be evaluated using standardized grid intraoral periapical radiographs (IOPA). This study determine whether local application of these gels improves implant stability and reduces crestal bone loss compared to control.

 
Close